
Relmada Therapeutics Inc (RLMD)
NASDAQ
The current RLMD market cap is 8.74M. The company's latest EPS is USD -3.2741 and P/E is -0.09.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.27M | -60.84M | -125.7M | -161.25M | -103.7M |
Net Income | -8.2M | -59.46M | -125.75M | -157.04M | -98.79M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 117.14M | 118.19M | 223.33M | 152.91M | 97.55M |
Total Liabilities | 1.46M | 12.6M | 15.06M | 12.47M | 12.2M |
Total Equity | 115.68M | 105.58M | 208.27M | 140.44M | 85.36M |
Market Cap | 8.74M |
Price to Earnings Ratio | -0.09 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.06 |
Price to Book Ratio | 0.1 |
Dividend Yield | - |
Shares Outstanding | 30.17M |
Average Volume (1 week) | 599.81k |
Average Volume (1 Month) | 2.13M |
52 Week Change | -94.92% |
52 Week High | 7.2225 |
52 Week Low | 0.28 |
Spread (Intraday) | 0.01 (5.07%) |
Company Name | Relmada Therapeutics Inc |
Address |
50 west liberty street suite 880 reno, nevada 89501 |
Website | https://www.relmada.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.